LOS ANGELES--(BUSINESS WIRE)--Oct. 13, 2005--Molecular Pharmacology (USA) Limited (OTCBB: MLPH) (“Molecular”) reports that it has entered into a Distribution and Supply Agreement (the “Agreement”) with Molecular Pharmacology Limited (“MPL”). MPL is incorporated under the laws of Australia and is a wholly-owned subsidiary company of Pharmanet Group Limited, an Australian company listed on the Australian Stock Exchange.
